First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025 Dupixent - global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD - U.S. net sales increased ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025; Dupixent ® global net sales (recorded by Sanofi) increased 33% to $4.9 billion ; EYLEA HD ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results